Filing search / Ownership / Delcath Systems, Inc. / Page 32

424B2

ywy4mhbcs sr

17 Aug 10

Prospectus for primary offering

12:00am

FWP

nloba2a

16 Aug 10

Free writing prospectus

12:00am

8-K

6sxhk

4 Aug 10

Regulation FD Disclosure

12:00am

8-K

dbuwrqbu5j5sam2aoah3

14 Jul 10

Departure of Directors or Certain Officers

12:00am

8-K

k1e5t5 ew6gqq0e007l3

17 Jun 10

Delcath Systems Inc. - Update Conference Call

12:00am

8-K

rw6u27p3rmm1rb

11 Jun 10

Provides Update on Recent ASCO Data Presentation and Current Financial Position

12:00am

8-K

7acl6

9 Jun 10

Regulation FD Disclosure

12:00am

8-K

4ucvwfc4u7a0

7 Jun 10

Delcath Highlights Phase III Trial Results Presented at ASCO

12:00am

S-8

4inodqi41kd721 vrh

19 May 10

Registration of securities for employees

12:00am

8-K

fqwcc

12 May 10

Submission of Matters to a Vote of Security Holders

12:00am

8-K

aw4eaebmqedp

11 May 10

Departure of Directors or Certain Officers

12:00am

8-K

751cn9e2 l34

26 Apr 10

Delcath Systems Appoints Peter J. Graham as Executive Vice President and General Counsel

12:00am

8-K

ag4no329a

21 Apr 10

Delcath Phase III Trial Results Exceed Primary Endpoint Expectations

12:00am

8-K

1tcu1q43po9hm

14 Apr 10

Delcath’s Phase III Trial Data to be Presented During American Society of Clinical Oncology 2010 Annual Meeting in Chicago

12:00am

EFFECT

cc5y6 12ggumf7f

13 Apr 10

Notice of effectiveness

12:00am

CT ORDER

5muj4nwde1dk

9 Apr 10

Confidential treatment order

12:00am